Funders › MO › Pkd Foundation › 2020
Grants paid by Pkd Foundation, tax year 2020
EIN 43-1266906 · Kansas City, MO · Form 990, Schedule I
In tax year 2020, Pkd Foundation (EIN 43-1266906) reported 10 grants paid totaling $1,355,964. Dataset version 2026.09.0, built 2026-09-03.
Every grant, 2020
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2020 | University of Kansas Medical School Kansas City, KS | A | $240,000 | paid | PRE-CLINICAL EVALUATION OF CASPASE 1 AS A THERAPEUTIC TARGET IN ADPKDRESCUING POLYCYSTIN-1 G-PROTEIN FUNCTIONUSE OF EXOSOMAL POLYCYSTIN-1 (PC1) LEVEL TO DIAGNOSE AND MONITOR ADPKD | 202100299349301100 |
| 2020 | Mayo Clinic Minneapolis, MN | A | $226,000 | paid | THE EFFECT OF DIETARY METHIONINE RESTRICTION ON PATHOGENESIS OF ADPKD AND THERAPEUTIC IMPLICATION OF FGF21 ANALOGUESROLE OF NOX4, MITOCHONDRIA AND RELATED BIOMARKERS IN ADPKD | 202100299349301100 |
| 2020 | University of Alabama at Birmingham Birmingham, AL | A | $209,964 | paid | DEVELOPING EARLY PROGNOSIS IMAGING BIOMARKERS OF ADPKD BASED ON DYNAMIC CHANGES IN CYST GROWN RATESKIDNEY SPECIFIC DRUG DELIVERY USING NANOPARTICLES IN PKD1 MICESALARY SUPPORT | 202100299349301100 |
| 2020 | University of Maryland Baltimore Baltimore, MD | A | $140,000 | paid | POLYCYSTIN-1 CLEAVAGE PRODUCT P100: DISTINCTIVE TOPOLOGY, SPECIFIC PROPERTIES, AND POLYCYSTIN-2-ASSOCIATED CHANNEL ACTIVITYRELIEVING THE STRESS OF PKD: A NEW ROLE OF PKHD1 IN DETOXIFICATION MEDIATED VIA DIFFERENTIAL CLEAVAGE OF THE INTRACELLULAR DOMAIN | 202100299349301100 |
| 2020 | University of Texas Southwestern Medical Center Irving, TX | A | $120,000 | paid | INVESTIGATING THE M6A RNA METHYLATION PATHWAY AS A THERAPEUTIC OPTION FOR ADPKD TREATMENTROLE OF TULP3-MEDIATED CILIARY PROTEIN TRAFFICKING IN KIDNEY CYSTOGENESIS | 202100299349301100 |
| 2020 | Critical Path Institute Tucson, AZ | A | $100,000 | paid | POLYCYSTIC KIDNEY DISEASE OUTCOMES CONSORTIUM | 202100299349301100 |
| 2020 | Brigham and Women's Hospital Boston, MA | A | $80,000 | paid | ELUCIDATING THE CYSTOGENIC PROTEOME IN POLYCYSTIC KIDNEY DISEASE | 202100299349301100 |
| 2020 | Emory University Decatur, GA | A | $80,000 | paid | MACHINE LEARNING FOR PREDICTING EGFR DECLINE IN THE CRISP COHORT OF ADPKD PATIENTS | 202100299349301100 |
| 2020 | University of Denver Denver, CO | A | $80,000 | paid | ADIPOSITY AND TIME RESTRICTED FEEDING IN ADPKD | 202100299349301100 |
| 2020 | Yale University New Haven, CT | A | $80,000 | paid | CONTROLLING THE VIABILITY OF PKD MUTANT CELLS VIA INACTIVATION OF XBP1 AS A NOVEL STRATEGY TO TREAT | 202100299349301100 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Derived from IRS Form 990 e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.